BioNTech SE Sponsored ADR BNTX 深 沪
交易中 03-27 10:18:24 美东时间
87.405
-0.105
-0.12%
华盛通- 最 高104.12
- 今 开87.62
- 成交量 3.11万股
- 最 低 79.52
- 昨 收 87.51
- 总市值 2123.94万
- 52周最高 124.00
- 市盈率 静 1.87
- 换手率 12.81%
- 52周最低 79.52
- 委 比 54.39%
- 总股本 0.00亿
- 历史最高 462.4502
- 量 比 0.51
- 振 幅 28.11%
- 历史最低 1.10
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls
BioNTech stock tumbled Tuesday as investors digested new questions. Here's what execs said on the earnings call.
03-11 03:39
US Stocks Mixed; United Natural Foods Shares Fall After Q2 Results
US stocks mixed, Dow down 0.1%, NASDAQ up 0.13%, S&P 500 down 0.08%. Materials sector up, utilities down. United Natural Foods stock falls 7%.
03-10 22:40
BioNTech Sees FY2026 Sales $2.328B-$2.678B vs $3.120B Est
BioNTech (NASDAQ:BNTX) sees FY2026 sales of $2.328 billion-$2.678 billion vs $3.120 billion analyst estimate.
03-10 18:49
Oracle, Ulta, Adobe, More Stocks With Earnings This Week
Investors are anticipating earnings releases from Oracle, Ulta, Adobe, Dick's, AeroVironment and more.
03-10 04:17
A Preview Of BioNTech's Earnings
BioNTech (NASDAQ:BNTX) is preparing to release its quarterly earnings on Tuesda...
03-09 22:01
Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars
Moderna shares jump after a $950 million settlement over COVID-19 vaccine patents, easing investor concerns and clearing legal uncertainty.
03-04 21:14
University of Pennsylvania, Osage University Partners Launch $50M Penn-BioNTech Innovative Therapeutics Seed Fund
The University of Pennsylvania ("Penn"), BioNTech SE ("BioNTech"), and OUP (Osage University Partners) announced the launch of the $50 million Penn-BioNTech Innovative Therapeutics Seed Fund ("PxB Fund"), a dedicated
01-09 23:04
Genmab Prunes Pipeline, Sharpens Focus On Late-Stage Cancer Assets
Genmab will discontinue clinical development of acasunlimab to focus on more promising late-stage programs in its portfolio.
2025-12-30 01:32
Pfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts
Pfizer previews 2026 guidance with earnings below consensus, softer sales outlook, COVID decline and LOE headwinds offset by pipeline growth.
2025-12-16 22:28
FDA Weighs Black Box Warning For COVID Vaccines, Experts Push Back
FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence.
2025-12-13 02:51
